US Corporate Distress Financial Stress SEC Filings — June 30, 2026

30-06-2026

Eos Energy Enterprises entered into a binding amended and restated term sheet with Cerberus Capital Management and Hudson Bay Capital to form a joint venture (Frontier Power USA Parent, LLC). Cerberus will contribute $100 million for Class A-2 Units and receive warrants for 20,017,772 shares, while Hudson Bay will contribute $50 million for Class C Units and receive warrants for 10,008,886 shares. Eos will fund its contribution via a $150 million rights offering at $5.481 per unit, but the transactions are subject to DOE consent and other conditions, with no guarantee of completion.

• · The JV Company board will have 7 members: 4 appointed by Cerberus and up to 3 by Eos (subject to ownership thresholds).
• · Day-to-day oversight of JV development projects will be delegated to a Cerberus affiliate via a management services agreement.
• · HBC has an exchange right for Class C Units into Eos common shares: before Dec 31, 2026, up to 50% at $15.00/share, up to 75% at $17.50/share, up to 100% at $20.00/share; after Dec 31, 2026, at the rights offering price.
• · Liquidation distributions follow a waterfall: first to Cerberus and Hudson Bay for return of invested capital (excluding Cerberus's pre-closing contribution), then to Eos, then to Cerberus for pre-closing contribution, then pro rata until 10% pre-tax IRR compounded quarterly, then to preferred and incentive unit holders.
• · The rights offering is limited to $150 million; Cerberus consent required for any excess.
• · Conditions to closing include DOE consent and execution of a Commercial Framework Guidelines.
• · RO Warrants and the Cerberus/HBC warrants each expire 10 years after closing.
• · RO Warrants and HBC/Cerberus warrants are exercisable on a cashless basis.

30-06-2026

Sadot Group Inc. sold 100% of its subsidiary Sadot Latam LLC to Dream America Marketing Services, Ltd for $1,000 cash plus a 27.5% profit-sharing payment on collected receivables. The transaction deconsolidates Sadot Latam from Sadot Group's financial statements, with the company evaluating the accounting impact for the quarter ending June 30, 2026. The sale includes assets such as a $250,000 Citizens Bank deposit and partial interests in certain receivables and litigation proceeds, but the nominal cash consideration and reliance on uncertain collections highlight a potential divestiture of a distressed or non-core asset.

• · The SPA is governed by New York law with disputes resolved via AAA arbitration in New York.
• · The seller agreed to provide legal support for six months post-closing for existing litigation and disputes.
• · The company expects to reflect deconsolidation effects in its Q2 2026 financial statements.
• · The financial effects of deconsolidation are preliminary, unaudited, and subject to change.

30-06-2026

Angel Studios amended its merger agreements to acquire Tuttle Twins Show (TTS) and Toothy Cow Productions (TCP), extending the outside closing date to October 31, 2026. The company has already provided $11.7 million in operational funding to TTS and $11.9 million to TCP, with conversion terms if the acquisitions fail. Related parties own 41.6% of TTS units and 2.4% of TCP units, highlighting significant insider involvement.

• · The A&R TTS Merger Agreement eliminated the requirement for a showrunner agreement with Daniel Harmon as a closing condition.
• · The A&R TCP Merger Agreement replaced the IP assignment agreement condition with a requirement for a new TCP A&R License Agreement.
• · Under the revised TCP Merger structure, Angel TCP Merger Sub will survive and TCP will cease to exist.
• · If the TTS acquisition fails, operational funding since September 10, 2025 converts to preferred units at $1.16 per unit.
• · If the TCP acquisition fails, operational funding converts to TCP Class B Preferred Units at $1.50 per unit plus a warrant to purchase TCP Common Units at a nominal strike price for each two Class B preferred units received.

30-06-2026

AMASS Brands Inc. entered into Amendment No. 2 to its SAFE agreement with AFTERDREAM, Inc., increasing the Purchase Amount from $1,535,000 to $1,735,000 (an additional $200,000 investment by the Company). The Post-Money Valuation Cap remains unchanged at $7,500,000, and all other material terms of the SAFE remain in effect. The amendment was executed on June 25, 2026, and disclosed via Form 8-K on June 30, 2026.

• · The SAFE was originally entered into on June 16, 2026, with Amendment No. 1 dated June 17, 2026.
• · The Second Amendment was executed on June 25, 2026, and the Form 8-K was signed on June 29, 2026.
• · The SAFE includes conversion mechanics upon an Equity Financing, Liquidity Event, or Dissolution Event.
• · Portions of the exhibit have been redacted pursuant to Item 601(b)(10)(iv) of Regulation S-K.

30-06-2026

Quantum Computing Inc. filed an 8-K announcing an amendment to its Certificate of Incorporation to increase authorized shares from 310,000,000 to 460,000,000, consisting of 450,000,000 shares of Common Stock and 10,000,000 shares of Preferred Stock. The amendment was approved by the Board of Directors and stockholders. No financial impact or performance metrics were disclosed.

• · The amendment increases total authorized shares from 310,000,000 to 460,000,000.
• · Common stock par value remains $0.0001 per share.
• · Preferred stock par value remains $0.0001 per share.
• · The amendment was adopted under Section 242 of the Delaware General Corporation Law.
• · Stockholders approved the amendment at a meeting called in accordance with Section 222.

30-06-2026

Creative Realities, Inc. announced the pricing of a $12 million underwritten public offering, issuing 2,528,571 shares of common stock at $3.50 per share and pre-funded warrants for up to 900,000 shares at $3.49 per warrant. The company expects to use net proceeds for working capital, debt paydown, and potential acquisitions, with the offering set to close around June 30, 2026. The company's performance and future outlook remain subject to risks including integration of the recently acquired CDM business and ability to continue as a going concern.

• · The company granted the underwriter a 30-day option to purchase up to an additional 428,614 shares at the public offering price, less underwriting discounts and commissions.
• · Proceeds from the offering will be used for working capital, general corporate purposes, debt paydown, and potential acquisitions.
• · Craig-Hallum is acting as sole managing underwriter.
• · The shelf registration statement (Form S-3, 333-296498) has been declared effective by the SEC.
• · The company cautioned about risks including integration of the recently acquired Cineplex Digital Media business, ability to realize anticipated synergies, and the risk of not being able to continue as a going concern.
• · No specific financial performance metrics (revenue, growth, etc.) were provided in this filing.

30-06-2026

Analysis unavailable

30-06-2026

Pacira BioSciences agreed to divest its iovera° business to Zimmer Biomet for up to $140 million, with $70 million upfront and up to $70 million in potential revenue-based milestones through 2031. The deal supports Pacira's 5x30 strategy and transition into an innovative biopharmaceutical company, while the companies will collaborate on advancing the spasticity program. However, the transaction is subject to customary closing conditions and is not expected to close until Q3 2026, and the milestone payments are contingent on future revenue performance, introducing uncertainty.

• · Pacira intends to use upfront net proceeds to pay down its senior secured revolving credit facility.
• · The parties will enter into a transition services agreement to support a smooth transition.
• · iovera° is an FDA-cleared, drug-free cryoneurolysis device for pain relief, including osteoarthritis knee pain for up to 90 days.
• · Pacira retains its other commercial-stage non-opioid treatments: EXPAREL and ZILRETTA.
• · Pacira's pipeline includes PCRX-201 (gene therapy for osteoarthritis) in Phase 2 development.
• · Closing expected in Q3 2026, subject to customary conditions.

30-06-2026

Aptevo Therapeutics Inc. (APVO) announced it has been awarded a $1.5 million non-dilutive research grant from the Andy Hill Cancer Research Endowment (CARE) Fund to support IND-enabling work for APVO451, its novel Nectin-4-targeted trispecific immunotherapy for solid tumors. The grant provides external validation of the program, which is advancing toward development candidate selection by year-end 2026 and IND-enabling studies in Q1 2027. No negative or flat financial metrics were reported in this filing.

• · APVO451 is a trispecific antibody-like immunotherapy targeting nectin-4, CD40, and CD3.
• · The grant supports preclinical studies and development work toward IND-enabling studies.
• · APVO451 incorporates Aptevo's CRIS-7-derived CD3 binding domain, the same platform used in mipletamig.
• · The program is designed to focus immune activation within the tumor microenvironment and reduce risk of systemic immune activation.
• · Aptevo's pipeline includes two clinical candidates and multiple preclinical programs.

30-06-2026

ZW Data Action Technologies Inc. (CNET) announced that its BVI subsidiary, CNET Technology Limited, will acquire an 8.0% equity interest in MARGO ASIA LIMITED from AFFIRM MISSION LIMITED for a total consideration of $600,000, comprising $474,000 in cash and 180,000 shares of CNET common stock valued at $0.70 per share ($126,000). The acquisition is subject to customary closing conditions.

• · The Purchaser is CNET Technology Limited, a wholly-owned BVI subsidiary of ZW Data Action Technologies Inc.
• · The Seller is AFFIRM MISSION LIMITED, a BVI company.
• · The target entity is MARGO ASIA LIMITED, also a BVI company.
• · The stock consideration is valued at $0.70 per share.
• · The acquisition agreement was entered into on June 26, 2026.
• · The filing was made on June 30, 2026.

30-06-2026

Stabilis Solutions, Inc. filed an 8-K on June 30, 2026, regarding a material agreement (Item 1.01) and a direct financial obligation or off-balance sheet arrangement (Item 2.03). The filing does not disclose specific financial terms or performance metrics.

• · The filing relates to a material agreement and a direct financial obligation or off-balance sheet arrangement.
• · The cover page is provided as an inline XBRL document.

30-06-2026

Ecovyst Inc. entered into a Fourth Amendment to its Term Loan Credit Agreement to secure $100M in incremental term loans, primarily to finance the acquisition of INEOS Calabrian Holdings Corp. and INEOS Calabrian Corporation Canada Inc. The amendment, effective June 30, 2026, adds a new $100M incremental term facility that is fungible with existing initial term loans. The acquisition is being executed through wholly owned subsidiaries pursuant to a Share Purchase Agreement dated May 1, 2026.

• · The Fourth Amendment was entered into on June 30, 2026, and amends the Existing Credit Agreement dated June 9, 2021, as previously amended in February 2023, June 2024, and January 2025.
• · The 2026 Incremental Term Loans are incurred under clause (c) of the definition of 'Incremental Cap'.
• · The proceeds will be used for purposes set out in Section 5.11(b) of the Amended Credit Agreement.
• · The amendment was arranged by a syndicate including Citi, BofA Securities, UBS Securities, Goldman Sachs, Deutsche Bank, KeyBanc Capital Markets, and Truist Securities.
• · Conditions to effectiveness included delivery of legal opinions, secretary's certificates, good standing certificates, and a borrowing request.

30-06-2026

Cuentas Inc. entered into an Amended and Restated Warrant Agency Agreement on June 29, 2026, extending the expiration date of its outstanding publicly traded warrants from June 30, 2026 to September 30, 2026. The agreement also allows the Board of Directors to voluntarily reduce the exercise price (currently $55.90 per share after a reverse stock split) and proportionately increase the number of shares purchasable. The extension aims to encourage warrant exercise to provide funds for operations as the company restructures its business and seeks financing.

• · The warrants were originally issued in February 2021 as part of an underwritten offering of units, each consisting of one share of common stock and one warrant.
• · The exercise price increased from $4.30 to $55.90 due to a 1-for-13 reverse stock split completed on March 24, 2023.
• · The company has applied to have its common stock and warrants listed on OTCQB.
• · The company has restructured its business and entered into a joint venture with World Mobile, LLC and World Mobile Media Group, LLC.

30-06-2026

Main Street Capital Corporation announced an amendment to its revolving credit facility, increasing total commitments from $1.175 billion to $1.240 billion, while maintaining an accordion feature allowing expansion up to $1.860 billion. The amendment also extends the revolving period through June 2030 and the final maturity date to June 2031, with options for up to two additional years subject to lender approval. The facility continues to benefit from a diversified group of 18 lenders.

• · The amendment maintains an expanded accordion feature allowing total commitments up to $1.860 billion on same terms and conditions as existing commitments.
• · The revolving period is extended through June 2030 and final maturity to June 2031.
• · Main Street retains options to extend both the revolving period and final maturity by up to two additional years, subject to lender approval.
• · The facility benefits from a diversified group of 18 lenders.

30-06-2026

Frontier Group Holdings extended its credit card affinity agreement with Barclays Bank Delaware through June 30, 2037, and increased its pre-purchased miles facility from $200 million to $375 million. The amendment includes enhanced net compensation and a pre-paid consideration received before June 30, 2026, which was slightly better than anticipated. However, the facility requires payback of any borrowed amounts beginning June 2036 in 12 equal monthly installments, and the actual facility size is subject to semi-annual program requirements.

• · The Seventh Amendment extends the term of the Credit Card Affinity Agreement from December 31, 2029 to June 30, 2037.
• · The pre-purchased miles facility's aggregate maximum increased from $200 million to $375 million, with actual size subject to semi-annual program requirements.
• · Payback of any borrowed amounts under the facility begins June 2036 in 12 equal monthly installments.
• · The amendment also modified certain financial covenants of the facility.
• · The pre-paid consideration was received by Frontier prior to the end of June 2026.

30-06-2026

MSP Recovery, Inc. disclosed a letter agreement with Hazel Partners Holdings LLC confirming a series of incremental fundings totaling $8,355,500 to increase the Operational Collection Floor under the existing Credit Agreement, plus an additional $550,000 for legal expenses. The lender also confirmed receipt of approximately $1,300,000 in HC Case Proceeds from property and casualty litigation, with $605,313 granted as collateral. While the additional financing provides liquidity, the reliance on discretionary lender funding and the estimated nature of the HC Case Proceeds introduce uncertainty.

• · The $208,000 funding on June 26, 2026 is at the sole discretion of the Administrative Agent and Lender, and no Event of Default may result from the borrowing.
• · The HC Case Proceeds of approximately $1,300,000 are from property and casualty litigation, with 50% due to Assignor and 50% to Assignee.
• · The $550,000 legal expense funding was provided to MSP Recovery, LLC on April 10, 2025.
• · The Aggregate Operational Collection Floor after all fundings is $8,355,500.
• · The lender reserves all rights under the Credit Agreement and may withhold further funding.

30-06-2026

MarineMax refinanced its $1.49 billion senior secured credit facilities, reducing borrowing costs, extending the maturity profile to June 2031, and expanding the revolving credit facility from $100 million to $150 million to enhance financial flexibility. The refinancing includes a $950 million floor plan line, a $302.5 million term loan, and an $85 million delayed draw mortgage facility (with $35 million drawn). While the company highlights improved terms and lender confidence, the filing does not disclose the prior borrowing costs or provide quantitative comparisons of interest savings, and the mortgage facility was reduced from $100 million to $85 million.

• · The new credit facilities mature in June 2031, extending the debt maturity profile by five years.
• · The mortgage facility was reduced from $100 million to $85 million, with only $35 million drawn.
• · M&T Bank acted as Administrative Agent and Joint Lead Arranger; Wells Fargo Commercial Distribution Finance served as Joint Lead Arranger and Floor Plan Agent.
• · MarineMax has over 120 locations worldwide, including over 70 dealerships and 65 marina and storage facilities.

30-06-2026

Envoy Medical terminated its at-the-market (ATM) equity facility effective June 24, 2026, citing confidence in its current capital position. The ATM facility had authorized up to $15 million in share sales. No negative or flat financial metrics were disclosed, and the filing focuses on a strategic reduction of equity dilution risk.

• · The ATM facility termination was effective June 24, 2026.
• · Envoy Medical's common stock trades under NASDAQ: COCH.
• · The Acclaim cochlear implant is an investigational device and received FDA Breakthrough Device Designation in 2019.
• · The Esteem FI-AMEI has been commercially available in the U.S. since 2010.

30-06-2026

Benchmark 2026-V22 Mortgage Trust filed an 8-K on June 30, 2026, reporting that servicing of two whole loans (ONX Industrial Campus and Marriott Savannah Riverfront) has been transferred to a new securitization trust (BBCMS 2026-5C42) under a new pooling and servicing agreement (PSA). The new PSA includes specific fee structures for special servicing, workout, and liquidation, with maximum fees capped at $1,000,000 and minimum fees of $25,000. Property inspection frequency varies based on loan principal balance, with higher-balance loans inspected every 12 months and lower-balance loans every 24 months.

• · The servicing transfer occurred upon issuance of BBCMS 2026-5C42 Certificates on June 24, 2026.
• · The new PSA is dated June 1, 2026.
• · Property inspection frequency: every 12 months for loans with principal balance >= $2,000,000; every 24 months for loans with principal balance < $2,000,000, starting calendar year 2027.
• · The filing amends a prior Form 8-K/A filed May 26, 2026.

30-06-2026

Disc Medicine, Inc. (IRON) amended its loan agreement with Hercules Capital, drawing down $30 million of the Tranche 1-B Advance and restructuring the remaining Tranche 1-C ($50 million) into two tranches: $25 million available through March 31, 2027, and $25 million (Tranche 1-D) available through April 30, 2027. The draw periods for Tranche 2 and Tranche 3 were extended to December 15, 2027 and June 30, 2028, respectively. While the amendment provides additional liquidity and flexibility by pushing the minimum cash covenant test date to July 1, 2028, the Company is incurring additional debt and may face future dilution or cash flow constraints.

• · The original Loan and Security Agreement was dated November 6, 2024.
• · Tranche 2 Advance draw period extended to December 15, 2027.
• · Tranche 3 Advance draw period extended to June 30, 2028.
• · Minimum cash covenant initial testing date moved to July 1, 2028.

30-06-2026

Granite Point Mortgage Trust Inc. (GPMT-PA) entered into the Fifteenth Amendment to its Master Repurchase Agreement with Morgan Stanley Bank, N.A., extending the facility termination date to June 28, 2027, and amending financial covenants. The amendment reduces the minimum Unrestricted Cash requirement to $20 million and sets a minimum Tangible Net Worth of $450 million. No material financial figures were disclosed regarding the size of the facility or current outstanding balances.

• · The amendment deletes definitions for 'Purchased Asset A', 'Purchased Asset B', 'Purchased Asset C', and 'Purchased Asset C Release Payment' from the Master Repurchase Agreement.
• · No Exit Fee shall be due when repurchasing assets to refinance under another facility.
• · Seller's address updated to 1114 Avenue of the Americas, Suite 3020, New York, NY 10036.
• · No Event of Default or Margin Deficit exists as of the amendment date.

30-06-2026

AquaBounty Technologies, Inc. filed a Certificate of Designation with the Delaware Secretary of State on June 25, 2026, establishing 200,000 shares of Series B Convertible Preferred Stock with a liquidation value of $20.60 per share. The Series B Preferred Stock carries an 18.0% per annum cumulative dividend rate, ranks senior to common stock and junior securities, and is pari passu with the existing Series A Preferred Stock. The filing also includes provisions for conversion, redemption, and voting rights tied to the underlying common stock.

• · Series B Preferred Stock ranks senior to all Junior Securities and pari passu with Series A Preferred Stock.
• · Dividends accrue quarterly at 18.0% per annum on the liquidation value, payable in cash bi-annually on the last day of October and April, unless the Board defers payment.
• · Dividends cannot be settled in Common Stock unless compliant with Nasdaq Listing Rule 5635(d) or stockholder approval is obtained.
• · Upon liquidation or Change of Control, holders may elect cash or non-cash consideration equal to the liquidation value plus all unpaid accrued dividends.
• · Each Series B Preferred Share votes with Series A and Common Stock as a single class, with votes equal to the number of Common Stock shares it is convertible into.
• · The filing was made under Items 1.01, 3.02, 3.03, 5.03, and 9.01 of Form 8-K.

30-06-2026

HighPeak Energy, Inc. entered into a Fourth Amendment to its Credit Agreement with Fifth Third Bank and other lenders, effective June 30, 2026. The amendment tightens the Total Net Leverage Ratio covenant from 2.50x to 2.25x for the quarter ending June 30, 2026, and further to 2.00x for quarters beginning September 30, 2026 onward. No material adverse effect has occurred since December 30, 2025, and no defaults are continuing.

• · The amendment was executed on June 30, 2026, and is effective as of the Fourth Amendment Effective Date (June 30, 2026).
• · The Total Net Leverage Ratio covenant steps down from 2.50x (for quarters ending Dec 31, 2025 and Mar 31, 2026) to 2.25x for the quarter ending June 30, 2026, and then to 2.00x for quarters ending September 30, 2026 and thereafter.
• · No Material Adverse Effect has occurred since December 30, 2025.
• · All representations and warranties remain true and correct, and no Default or Event of Default exists.
• · The amendment was consented to by all Guarantors (HighPeak Energy Holdings, LLC; Lazy JJ Properties, LLC; HighPeak Energy Acquisition Corp.; HighPeak Energy Assets, LLC; HighPeak Energy Employees, Inc.) and Lenders (Fifth Third Bank and Texas Capital Bank).

30-06-2026

BlackRock Monticello Debt Real Estate Investment Trust, through its subsidiary BLKM I, LLC, entered into a First Amendment to its Master Repurchase Agreement and Securities Contract with Natixis, New York Branch, dated June 24, 2026. The amendment modifies the existing agreement originally dated May 23, 2025, with specific changes detailed in attached exhibits. The filing does not disclose any financial amounts or performance metrics, and no negative or flat performance data is mentioned.

• · The amendment was executed on June 24, 2026, and filed on June 30, 2026.
• · The original Master Repurchase Agreement was dated May 23, 2025.
• · The amendment includes modifications to the existing agreement as set forth in Exhibit A, which is attached but not fully detailed in the filing.
• · The amendment is governed by the laws of the State of New York.
• · The Guarantor reaffirmed its obligations under the Guaranty.
• · No financial terms, amounts, or performance metrics are disclosed in this filing.

30-06-2026

Westrock Coffee Company announced an amendment to its credit agreement, extending the maturity of approximately $361 million in loans and commitments from August 2027 to November 2028. The company also elected to terminate its covenant relief period early, reducing borrowing costs and lowering the maximum secured net leverage ratio to 4.00x for upcoming test periods. While this provides improved financial flexibility and signals momentum, the company still faces risks related to its Conway facility ramp-up and overall leverage.

• · The maturity extension applies only to ~$361M of the total debt; ~$26M still matures in August 2027.
• · The company terminated the covenant relief period before its scheduled October 1, 2026 expiration, reducing borrowing costs.
• · The maximum secured net leverage ratio covenant decreases to 4.00x for the June 30, 2026 test period (down from 5.00x) and to 4.00x for the September 30, 2026 test period (down from 4.50x).
• · Texas Capital Bank was added as a new lender in the syndicate.

30-06-2026

Blue Owl Capital Corp (OBDC) entered into a Third Amendment to its Senior Secured Revolving Credit Agreement, effective June 25, 2026, which reduces commitments of certain lenders (including departing lenders City National Bank and Valley National Bank) and adds new lenders. The amendment does not disclose the updated total commitment amount or any new financial terms, and the borrower reaffirms that no default or event of default exists.

• · Two departing lenders: City National Bank and Valley National Bank will cease to be lenders after commitment reductions.
• · The amendment involves new lenders joining as Revolving Lenders, but specific commitment amounts are redacted or not detailed in the filing excerpt.
• · No Event of Default was declared immediately before or after the amendment.
• · The amendment was dated June 25, 2026, and filed on June 30, 2026.

30-06-2026

Worthington Steel, Inc. entered into a Credit Agreement dated June 25, 2026 with Wells Fargo Bank as administrative agent and several other lenders as joint lead arrangers. The agreement establishes a revolving credit facility with borrowing base determined by eligible receivables and inventory, with applicable margins ranging from 1.250% to 1.375% for SOFR loans based on average excess availability. The facility is secured by ABL Priority Collateral and coordinates with the company's existing 7.750% Senior Secured Notes due 2033 issued on June 1, 2026 and a separate intercreditor agreement also dated as of the closing date.

• · The Credit Agreement was signed June 25, 2026, two days before filing date of June 30, 2026.
• · Acquisition closing date referenced as June 3, 2026, indicating a recent acquisition occurred before this credit agreement.
• · The 2033 Senior Secured Notes were issued under an indenture dated June 1, 2026.
• · Borrowing base is subject to Advance Rates (not specified in excerpt) on eligible accounts receivable and inventory.
• · The facility includes a 'KLöckner Commitments' condition precedent, suggesting a portion of commitments tied to a specific acquisition or entity.
• · Alternative currency available only for Canadian Dollars.
• · Interest rate options: SOFR Loans and Base Rate Loans, plus a Term SOFR Option.
• · Typical negative covenants included: restrictions on Indebtedness, Liens, Investments, fundamental changes, asset dispositions, restricted payments, transactions with affiliates, and sale-leasebacks.
• · Financial covenant requires compliance measurement (covenant not detailed in excerpt).
• · Events of default include cross-default on other Indebtedness, Change in Control, bankruptcy, ERISA events, and judgment defaults.

30-06-2026

W. P. Carey Inc. priced a $350 million public offering of 5.200% Senior Notes due 2036 at 99.015% of par, with net proceeds intended to repay $350 million of 4.250% Senior Notes due October 2026 and for general corporate purposes. The offering is expected to settle on July 2, 2026, and the new notes carry a higher coupon (5.200%) than the notes being refinanced (4.250%), reflecting higher interest costs. The company maintains a large net lease portfolio of 1,703 properties covering ~185 million square feet as of March 31, 2026.

• · Interest on the new Notes will be paid semi-annually on March 15 and September 15, beginning March 15, 2027.
• · Joint book-running managers: Wells Fargo Securities, RBC Capital Markets, U.S. Bancorp Investments, and BBVA Securities.
• · The company's portfolio includes 1,703 net lease properties covering ~185 million square feet as of March 31, 2026.
• · Offices located in New York, London, Amsterdam, and Dallas.
• · The company focuses on single-tenant industrial, warehouse, and retail properties in the U.S. and Europe under long-term net leases with built-in rent escalations.

30-06-2026

Verizon Master Trust issued $1.2B in asset-backed notes (Series 2026-2) across four tranches on June 30, 2026, with a combined initial balance of $1,200,000,000. The largest tranche, Class A-1a, accounts for $994,210,000 of the total. The filing includes executed agreements such as the Indenture and Series 2026-2 Account Control Agreement. No period-over-period comparisons are available as this is a single issuance event.

• · The Notes were issued under a final prospectus dated June 25, 2026.
• · The Indenture was between Verizon Master Trust and U.S. Bank Trust Company, National Association, as indenture trustee and note paying agent.
• · The Series 2026-2 Account Control Agreement was among the Trust, U.S. Bank Trust Company, National Association, as secured party, and U.S. Bank National Association, as financial institution.
• · References to previous filings include amendments from 2021 through 2025, indicating an ongoing structured finance program.
• · The Notes are asset-backed securities secured by receivables of the Trust.
• · Class A-1a notes represent 82.85% of the total issuance; Class A-1b: 6.25%; Class B: 6.81%; Class C: 4.09%.

30-06-2026

Fox Corporation entered into a $1,000,000,000 term loan credit agreement dated June 30, 2026, with Morgan Stanley Senior Funding, Inc. as administrative agent and joint lead arranger alongside Citibank, Deutsche Bank, Goldman Sachs, and JPMorgan Chase. The proceeds will be used to finance the acquisition of a target company (the 'Acquired Business') under a merger agreement dated June 14, 2026. The credit agreement includes financial covenant requirements based on Adjusted Operating Income and a leverage ratio.

• · The credit agreement has a facility size of $1,000,000,000 (original amount) with joint lead arrangers including Morgan Stanley, Citibank, Deutsche Bank, Goldman Sachs, and JPMorgan Chase.
• · Interest rate margins range from 0.875% (Term SOFR) at highest credit rating to 1.375% at lowest; Base Rate margins range from 0.000% to 0.375%.
• · Commitment fee rates range from 0.070% to 0.175% per annum based on public debt ratings.
• · The acquisition target is acquired under an Agreement and Plan of Merger dated June 14, 2026, and the transaction is expected to close subject to conditions precedent including solvency certificate delivery.

30-06-2026

Mobile Infrastructure Corporation (BEEP) entered into a Fourth Amendment to its Credit Agreement with Harvest Small Cap Partners, extending the maturity date and modifying terms of its $40.4 million subordinated unsecured credit facility. The amendment, effective June 29, 2026, represents continued reliance on debt financing from a single lender group, with no new capital raised or operational changes disclosed.

• · The credit facility is subordinated and unsecured.
• · The facility was originally dated September 11, 2024, with prior amendments on September 5, 2025, December 23, 2025, and March 24, 2026.
• · The amendment extends the maturity date (specific new date not disclosed).
• · The Borrower represented that no Default or Event of Default exists as of the Fourth Amendment Effective Date.
• · The facility is provided by a single lender group (Harvest Small Cap Partners entities).

30-06-2026

Talos Energy announced a strategic acquisition of deepwater Gulf of America assets from Shell for $850 million net to Talos, funded via cash on hand and debt, with $150 million in new incremental commitments increasing its borrowing base to $850 million. The deal is expected to be immediately accretive to key financial metrics, adding 23 MMBoe of proved reserves and 10 MMBoe of probable reserves, with Q1 2026 production of 16 MBoe/d (~77% oil). However, the acquisition is subject to a 30-day preferential right held by BP on the Na Kika interests, which if exercised would reduce Talos's acquisition to only the Coulomb field, and the first oil from the Monument development well is not expected until late 2026.

• · The acquisition includes a 50% working interest and operatorship of the Coulomb field (Shell's exclusive) and a 25% non-operated working interest in the BP-operated Na Kika platform and four associated fields (Kepler, Ariel, Fourier, Herschel).
• · The acquisition is subject to a 30-day preferential right held by BP affiliates on the Na Kika interests; if exercised, Talos would only acquire the Coulomb field.
• · The company successfully completed the Genovesa workover and returned the well to production late in Q2 2026.
• · First Monument development well drilled to 32,250 feet with 245 feet of net pay; first oil expected by late 2026.
• · Upside sharing agreement effective at closing through year-end 2027 if realized price exceeds $60/Bbl.
• · Closing expected by end of 2026, subject to HSR Act and preferential purchase rights.

30-06-2026

Patrick Industries (PATK) and LCI Industries (LCII) announced a definitive all-stock merger agreement to create a premier component solutions provider for outdoor enthusiast, housing, and transportation markets. Patrick shareholders will own approximately 52% of the combined company, with expected pro forma revenue of $8.1B and adjusted EBITDA of $1.0B inclusive of $150M+ in run-rate cost synergies. The transaction is expected to close in the first half of 2027, subject to shareholder and regulatory approvals.

• · Exchange ratio: LCI shareholders will receive 1.2440 shares of Patrick common stock for each LCI share.
• · Pro forma net leverage expected at 2.1x, with a target range of 2.25x to 2.5x.
• · Combined company will be headquartered in Elkhart, Indiana.
• · Transaction expected to close in first half of 2027.
• · Synergies identified in procurement, SG&A, engineering, and supply chain management.
• · Combined company will have a balanced dividend policy and share repurchase program as part of capital allocation.

30-06-2026

Seadrill Ltd issued $700 million in 6.750% Senior Notes due 2034, using proceeds to redeem its 8.375% Senior Secured Second Lien Notes due 2030 and amend its revolving credit facility, increasing commitments from $225 million to $300 million. The refinancing reduces interest cost and extends maturities, but adds leverage with new debt.

• · The new Notes mature on July 15, 2034, with interest payable semi-annually on January 15 and July 15, starting January 15, 2027.
• · The Issuer may redeem up to 40% of the original aggregate principal amount of the Notes with net cash proceeds from equity offerings before July 15, 2029, at 106.750% of principal.
• · The Indenture contains covenants restricting incurrence of additional debt, liens, distributions, asset sales, affiliate transactions, and mergers, subject to exceptions and suspension if the Notes achieve investment grade ratings from at least two rating agencies.
• · Upon a Change of Control Triggering Event, the Issuer must offer to repurchase the Notes at 101% of principal plus accrued interest.
• · The revolving credit facility under the Credit Agreement has not been drawn to date.

30-06-2026

Advanced Biomed Inc. (ADVB) entered into a Share Purchase Agreement to sell its wholly-owned Taiwan subsidiary for $490,000 cash. The subsidiary conducts biomedical R&D including the A+PerfusC platform; post-sale, ADVB will focus on AI operations via Acellent Technologies (Hong Kong). The transaction is expected to close within three months.

• · The Taiwan subsidiary is a wholly-owned subsidiary of Advanced Biomed Inc.
• · The buyer is an unrelated third party, Miaozhu Zhao.
• · The agreement was entered into on June 30, 2026.
• · The closing is expected within three months from the agreement date.
• · Post-transaction, ADVB will continue AI-focused operations through Acellent Technologies (Hong Kong) Co. Limited.

30-06-2026

Advanced Flower Capital Inc. (AFCG) entered into Amendment Number Nine to its Loan and Security Agreement on June 26, 2026, which increased aggregate revolver commitments to $110 million, including a $30 million temporary increase. However, upon expiration of the Temporary Increase Period, commitments will automatically reduce to $80 million, indicating a net $30 million reduction from the temporary peak. The amendment also conformed reporting standards for business development companies and set conditions for including specific credit facilities.

• · The amendment was effective June 26, 2026, and filed on June 30, 2026.
• · The original Loan and Security Agreement was dated April 29, 2022.
• · The Ninth Amendment conforms reporting information to market standard for business development companies.
• · Specific conditions were set for including certain credit facilities in the borrower base.

30-06-2026

Vistra Operations Company LLC entered into an Eighteenth Amendment to its Credit Agreement, increasing total 2026 Revolving Credit Commitments by an undisclosed amount to $5.5 billion and establishing new Specified Letter of Credit Commitments totaling $5.475 billion. The amendment also releases guarantees, removes collateral reinstatement requirements, and appoints new Letter of Credit Issuers. No negative or flat performance metrics are present as this is a financing transaction.

• · The amendment releases each Guarantor from its Guarantee related to Revolving Credit Loans, Revolving Credit Commitments, Letters of Credit, Letter of Credit Commitments, and Secured Cash Management Agreements.
• · Collateral reinstatement requirements in the Credit Agreement (including Section 9.17) are removed.
• · Ratings requirements for determining Applicable Revolving Margin are adjusted.
• · The Intercompany Subordinated Note is released and terminated.
• · New Letter of Credit Issuers appointed: Banco Santander, PNC Bank, U.S. Bank, and Wells Fargo.
• · A fee of 0.15% of each 2026-A New Revolving Loan Lender's commitment was paid to the Administrative Agent for ratable account of 2026 Revolving Credit Lenders.

30-06-2026

VisionWave Holdings, Inc. has entered into a definitive agreement to acquire a 51% controlling interest in Meteor Aerospace Ltd. for approximately $20.4 million in VisionWave common stock, valuing Meteor at a pre-money equity valuation of $40 million. The acquisition is subject to closing conditions including successful flight validation of Meteor's Impact-700 UAV and completion of due diligence. The transaction presents a strategic expansion into advanced unmanned systems, electronic warfare, and C4ISR solutions but carries significant completion risk, as there is no assurance the deal will close.

30-06-2026

Gulf Resources, Inc. (GURE) received an extension from Nasdaq on June 25, 2026 to regain compliance with Listing Rule 5250(c)(1) by filing its delinquent Annual Report (Form 10-K) for the year ended December 31, 2025 and Quarterly Report (Form 10-Q) for the period ended March 31, 2026. The company remains delinquent as of the filing date, and while Nasdaq's extension provides temporary relief, failure to evidence compliance by filing the reports will result in delisting proceedings. There is no assurance the company will regain compliance within the plan period.

• · Nasdaq originally issued deficiency notifications on April 23, 2026 and May 26, 2026 due to failure to timely file the Form 10-K and Form 10-Q.
• · The Compliance Plan was submitted on June 17, 2026.
• · The Extension Letter explicitly warns that if the company fails to evidence compliance after filing the delinquent reports, the Staff will notify the company that its securities will be subject to delisting.
• · The extension has no immediate effect on the listing or trading of GURE common stock on Nasdaq, subject to compliance with other listing requirements.

30-06-2026

Tenax Therapeutics entered into a Supply Agreement with Orion Corporation for the manufacture and supply of its orally administered levosimendan product, with an initial five-year term and automatic three-year renewals. Concurrently, the companies executed the Sixth Amendment to the License Agreement, extending the regulatory approval milestone deadline to December 31, 2035, and adding information and cybersecurity requirements. The agreements secure a key supply chain for the Oral Product and provide additional time to achieve U.S. regulatory approval, but no financial terms or revenue figures were disclosed.

• · The Supply Agreement includes cost-sharing provisions for scaling up Orion's manufacturing capabilities.
• · Either party may terminate the Supply Agreement for material breach (60-day cure period), insolvency, or termination of the License Agreement.
• · The Sixth Amendment extends the regulatory approval deadline from an unspecified prior date to December 31, 2035.
• · The Sixth Amendment also requires Tenax to comply with certain information and cybersecurity requirements of Orion.
• · The License Agreement was originally dated September 20, 2013, and has been amended six times (October 9, 2020; January 25, 2022; February 19, 2024; October 2, 2024; September 3, 2025; and June 29, 2026).

30-06-2026

GAMCO Natural Resources, Gold & Income Trust (GNT) entered into an amendment to its sales agreement on June 30, 2026, allowing the Fund to offer and sell up to 2,000,000 common shares at-the-market, with a minimum price not less than the then current net asset value per share plus the per share commission. The offering is made under a shelf registration statement and is being conducted through G.research, LLC as Sales Manager. No financial results or period-over-period comparisons are provided in this filing.

• · The amendment was entered into on June 30, 2026, amending the original sales agreement dated April 22, 2025.
• · The offering is made pursuant to a prospectus supplement dated June 30, 2026 and an accompanying prospectus dated February 5, 2024, under shelf registration statement on Form N-2 (File No. 333-276020).
• · The minimum sale price per share on any day is the then current net asset value per share plus the per share commission to the Sales Manager.
• · The Fund's common shares trade on NYSE under ticker GNT; Series A Cumulative Preferred Shares trade under GNT Pr A.

30-06-2026

Nuvectis Pharma announced a proposed underwritten public offering of its common stock to fund development of its pipeline candidates NXP100, NXP200, and NXP900. The offering is subject to market conditions, with Cantor acting as sole book runner, and net proceeds will also support hiring, capital expenditures, and general corporate purposes. No specific offering size or pricing terms were disclosed, and there is no assurance the offering will be completed.

• · The offering is made under an effective shelf registration statement on Form S-3 (File No. 333-293459) filed February 13, 2026 and declared effective February 20, 2026.
• · Cantor Fitzgerald & Co. is the sole book runner for the offering.
• · The underwriters have a 30-day option to purchase up to an additional 15% of the shares offered.
• · Nuvectis is a clinical-stage biopharmaceutical company focused on immune complement-related conditions and oncology.
• · NXP100 is described as a late-stage Factor B inhibitor with best-in-class potential and once-daily oral dosing.
• · NXP200 targets BRAF V600X-mutated and Class II/III non-V600-mutated solid tumors including CNS cancer, colorectal cancer, melanoma, and NSCLC.
• · NXP900 inhibits both catalytic and scaffolding functions of SRC kinase.

30-06-2026

Summit Hotel Properties, Inc. entered into a Second Amended and Restated Credit Agreement dated June 29, 2026, among Summit Hotel OP, LP as borrower, Summit Hotel Properties, Inc. as parent guarantor, and a syndicate of lenders led by Bank of America, N.A. as administrative agent. The agreement establishes a term loan facility, a revolving facility, and a delayed draw term loan facility, with multiple co-syndication and co-documentation agents. No specific dollar amounts or financial terms are disclosed in the filing.

• · The credit agreement includes CUSIP numbers: 86607VAU1 (Term Loan Facility), 86607VAW7 (Revolving Facility), 86607VAV9 (Delayed Draw Term Loan Facility), and 86607VAX5.
• · The agreement is governed by the laws of the State of New York.
• · The Borrower is Summit Hotel OP, LP, a Delaware limited partnership.
• · The Parent Guarantor is Summit Hotel Properties, Inc., a Maryland corporation.
• · The agreement includes provisions for guaranty by subsidiary guarantors and a keepwell provision.

30-06-2026

KORU Medical Systems entered into Amendment No. 1 to its Manufacturing and Supply Agreement with Command Medical Products on June 24, 2026, extending the initial term to December 31, 2031, modifying pricing and payment terms, and requiring Command to obtain a second manufacturing site by December 31, 2027. The amendment also establishes Command as exclusive manufacturer for a limited set of products, clarifies IP ownership, and removes a non-competition provision. No financial terms were disclosed.

• · Amendment extends initial term to December 31, 2031, with automatic one-year renewals unless 180 days' notice given.
• · Command must obtain and qualify a second manufacturing site by December 31, 2027; failure gives KORU termination right with 30-day cure.
• · Command becomes exclusive manufacturer for a limited set of Products.
• · Non-competition provision removed; assignment rights made mutual.
• · Termination rights unchanged except for additional right related to second site failure.

30-06-2026

LTC Properties, Inc. entered into a Second Amendment to its Credit Agreement on June 26, 2026, increasing total commitments to $1.1 billion and the revolving credit commitment to $900 million. The amendment also adds a new revolving lender and makes other modifications to the credit facility. No defaults or material adverse changes were reported as of the effective date.

• · The amendment is dated June 26, 2026, and was filed on June 30, 2026.
• · The original Credit Agreement was dated July 21, 2025, and was previously amended on December 12, 2025.
• · A new revolving lender (Hancock Whitney Bank) joined the facility.
• · The amendment includes a sustainability-linked margin adjustment provision (Section 2.17).
• · The borrower represented that no Default or Event of Default existed as of the amendment effective date.
• · The amendment was executed by multiple lenders including KeyBank, Citizens Bank, U.S. Bank, Huntington National Bank, Wells Fargo, Royal Bank of Canada, M&T Bank, and Hancock Whitney Bank.

30-06-2026

Lumexa Imaging Holdings, Inc. entered into Amendment No. 7 to its Credit Agreement on June 30, 2026, establishing $822,937,500 in new replacement term loans (Amendment No. 7 Replacement Term Loans) to refinance existing Amendment No. 5 Replacement Term Loans and pay related fees. The amendment also reduces the interest rate on revolving loans, with the new term loans initially bearing interest at SOFR + 2.50% or Base Rate + 1.50%. However, the refinancing introduces a 1.00% prepayment premium if the loans are repriced within six months, and the quarterly amortization is minimal at 0.25% per quarter, indicating a back-loaded repayment structure.

• · The amendment was executed on June 30, 2026, and is effective upon satisfaction of conditions including receipt of executed counterparts and KYC documentation.
• · The new term loans are designated as a new class under the Credit Agreement and will be repaid in equal quarterly installments of 0.25% of the aggregate principal amount, with the remaining balance due on the Original Term Loan Maturity Date.
• · The amendment includes a 1.00% prepayment premium if the loans are repriced within six months of the effective date.
• · The interest rate on revolving loans is reduced, with a grid based on Senior Secured Net Leverage Ratio (ranging from 2.00% to 2.50% for SOFR Loans and 1.00% to 1.50% for Base Rate Loans, and commitment fee rate from 0.25% to 0.50%).
• · The lead arrangers for the amendment include Barclays, JPMorgan, Jefferies, Deutsche Bank, Wells Fargo, Capital One, Fifth Third, PNC, and Sumitomo Mitsui.

30-06-2026

Valvoline Inc. entered into Amendment No. 1 to its Second Amended and Restated Credit Agreement on June 30, 2026, refinancing its existing Term B Loans through a combination of a cashless conversion for certain lenders and new cash-funded Term B Loans. The amendment includes updated terms, schedules, and conditions for the new debt class, with proceeds used to repay non-converted loans and accrued interest. No specific dollar amounts for the refinancing or interest rates are disclosed in the filing.

• · The refinancing was effected under Section 2.17 of the original Credit Agreement dated December 1, 2025.
• · Initial Term B Lenders could either convert their loans cashlessly into the new class or receive cash repayment and purchase assignments from new lenders.
• · New Amendment No. 1 Term B Lenders funded cash loans, the proceeds of which were applied to repay non-converted Initial Term B Loans.
• · The Amendment No. 1 Effective Date is June 30, 2026.
• · Conditions to effectiveness included execution by all parties, compliance with representations, no default, delivery of certificates and legal opinions, and satisfaction of know-your-customer requirements.

30-06-2026

SolarMax Technology, Inc. (SMXT) received a Nasdaq notice on June 22, 2026, for failing to maintain a minimum market value of listed securities of $35 million (Rule 5550(b)(2)). The company has a 180-day compliance period expiring December 21, 2026, and must achieve a market value of at least $35 million for ten consecutive business days to regain compliance. This notice is in addition to a prior Nasdaq notice for failing to maintain a minimum bid price of $1.00 per share, indicating multiple listing standard deficiencies.

• · The delisting notice is in addition to a previously announced notice for failure to maintain a minimum bid price of $1.00 per share.
• · The compliance period expires on December 21, 2026.
• · To regain compliance, the market value of listed securities must be at least $35 million for a minimum of ten consecutive business days.
• · If compliance is not regained, the company will receive written notification that its securities are subject to delisting.

30-06-2026

Nuvation Bio announced a proposed $200.0 million offering of Convertible Senior Notes due 2032, with an underwriter option for an additional $30.0 million. The company expects to use net proceeds to pay for capped call transactions, repay its senior secured loan, and for general corporate purposes. The offering is subject to market conditions and may dilute existing shareholders upon conversion.

• · The Notes will mature on July 1, 2032, unless earlier converted, redeemed or repurchased.
• · Interest will be payable semiannually in arrears.
• · Upon conversion, Nuvation Bio may pay or deliver cash, shares of Class A common stock, or a combination.
• · The interest rate, initial conversion rate, and other terms will be determined at pricing.
• · Capped call transactions are expected to reduce potential dilution upon conversion and/or offset cash payments in excess of principal.
• · Option Counterparties may enter into derivative transactions that could affect the market price of the common stock or Notes.
• · The offering is made under a shelf registration statement (File No. 333-285621) effective March 6, 2025.
• · Joint bookrunning managers: Jefferies, Citigroup, Cantor Fitzgerald; bookrunner: RBC Capital Markets.

30-06-2026

Non-Invasive Monitoring Systems, Inc. (NIMU) entered Amendment No. 1 to its merger agreement with Gravitics, Inc., extending the outside termination date and adding resale registration rights for a convertible note holder. No financial terms or performance data are disclosed in this filing.

• · The amendment revises closing conditions in Sections 5.1 and 5.3 of the original merger agreement.
• · The registrant's common stock is not listed on any national exchange (trading symbol NIMU, no exchange specified).